Offsetting toxicity of antineoplastic agents
β Scribed by Dr. Elton S. Cook; Leo G. Nutini; John C. Fardon; M. Agnes Bernadette Proudfoot; M. Eymard Poydock
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 397 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
PCO, a yeast extract, offsets at least in part the mitotic inhibitory effect of methotrexate and fluorouracil on bone marrow cells in vitro but increases the antimitotic activity of the drugs on ascites Krebsβ2 carcinoma under similar conditions. In vivo, PCO enhances the action of methotrexate against the Lβ1210 lymphoid leukemia and does not interfere with the effectiveness of fluorouracil against the ascites Krebsβ2 tumor.
π SIMILAR VOLUMES
Ametantrone acetate (anthracenedione diacetate, NSC 2875 13) is an experimental antineoplastic agent with activity against a comprehensive panel of solid transplantable tumors in mice. The studies reported here were aimed at establishing the toxicologic profile of this drug. Studies in mice and dogs
Ellipticine, a poorly water-soluble alkaloid, is active in several experimental tumor systems. Marked solubility increases were produced by polyvinylpyrrolidone of varying molecular weights (10,000--160,000) and were optimal (approximately 13 mg/ml at 25 degrees) with polyvinylpyrrolidone mol. wt 10